StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
221980.KQ$9870.00+0.00%
Fair $9870.00+0.0%

221980.KQ

KD Chem Co., Ltd.

Basic Materials / Specialty ChemicalsKOSDAQ

$9870.00

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $9870.00Fund rank 36/100 · Data gapFallback financials|
SA 40/C
F-Score: 5/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 24% · confianza 25%

FCF escenarios

weak_data · normalized FCF $6.0B · quality 75.0/100

Data gap 36/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 69/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

40/100

C

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. ROE is 3.4%, below the 5% threshold
Thesis & Journal · 221980.KQLocal privado en este navegador · KD Chem Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$37.0B

P/E

10.5x

↓

EV/EBITDA

2.1x

↓

ROE

3.4%

↑

Gross Margin

23.7%

↑

Debt/Equity

0.20

↓
52-Week Range$9870
$9610$11620

TradingView lightweight chart

221980.KQ price, volumen y niveles de valoración

Último $9,870Periodo -21.7%
Fair value: $9,870

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+0.4%

FCF CAGR

+66.2%

FCF margin

9.6%

FCF / Net income

1.71x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $62.90B · net income $3.51B · FCF $6.01B

2022-FY → 2025-FY

Gross margin

23.7%+3.5% pts

Operating margin

11.1%+1.9% pts

Net margin

5.6%-7.6% pts

FCF margin

9.6%+7.4% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$62.90B$62.90B$62.42B$59.15B$62.12B
Net Income$3.51B$3.51B$5.39B$5.32B$8.16B
EBITDA$4.76B$4.76B$9.82B$6.95B$9.24B
EPS936.00936.001424.001391.002136.00
Gross Margin23.7%23.7%24.6%22.2%20.1%
Operating Margin11.1%11.1%12.0%10.6%9.2%
Net Margin5.6%5.6%8.6%9.0%13.1%
Balance Sheet
Debt/Equity0.200.200.250.200.22
Current Ratio2.282.28———
Cash Flow
Free Cash Flow$6.01B$6.01B$6.43B$5.59B$1.31B
Returns
ROE3.4%3.4%5.3%5.3%8.5%
Valuation
P/E10.5410.547.918.916.04
EV/EBITDA2.052.052.294.103.34
P/B0.360.360.420.480.51
Growth & Yield
Revenue Growth0.8%0.8%5.5%-4.8%—
EPS Growth-34.3%-34.3%2.4%-34.9%—
Dividend Yield5.1%5.1%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-2.2%

fácil

EPS terminal req.

$875.80

Spread vs growth

-32.1%

5Y implied EPS CAGR

2.5%

fácil

EPS terminal req.

$1059.72

Spread vs growth

-36.8%

10Y implied EPS CAGR

6.2%

razonable

EPS terminal req.

$1706.68

Spread vs growth

-40.5%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -8.4%

Total return

-8.4%

Start / end P/E

8.0x → 10.5x

EPS bridge

1424.00 → 936.00

Residual

-10.9%

EPS growth-34.3%
Multiple rerating+31.7%
Dividend+5.1%
Residual / FX / buybacks / cross-term-10.9%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.